POWAY, Calif., April 24 /PRNewswire-FirstCall/ -- Digirad
Corporation (NASDAQ:DRAD), a leading provider of medical diagnostic
imaging systems and services to physicians' offices, hospitals and
imaging centers, today reported financial results for first quarter
ended March 31, 2008. Consolidated revenues were higher, compared
to the same time period in 2007, due to an increase in mobile
imaging services revenues within Digirad Imaging Solutions. The
Company's product division experienced a downturn in large part due
to the difficult market conditions during the quarter. Operating
expenses were relatively unchanged from the year ago period, but
the effects of weaker margins and lower product sales contributed
to the loss in the quarter. Chief Executive Mark Casner commented:
"We are clearly disappointed with the performance of our product
division during first quarter, but we remain cautiously optimistic
that these results reflect more of an acute phase than a systemic
problem. And while it can be difficult to predict future results,
early indications show that bookings and shipments have picked up
during the first few weeks of April. "In late third-quarter 2007,
we launched labor-retention initiatives to reduce turnover in the
DIS division," Casner continued. "I am pleased to report that these
initiatives have produced some positive results, but they have also
contributed to the squeeze on margins this quarter. As a result, we
are evaluating these initiatives and will likely refine them this
quarter to address this issue." Growth of DIS services revenues in
first quarter, compared to first-quarter 2007, was the result of
incremental revenue from ultrasound imaging that in second-quarter
2007 Digirad added to its line of mobile imaging services.
According to Casner, ultrasound business is progressing well
according to plan. DIS now accounts for more than 75 percent of
total revenues, and the Company's centers of influence are
beginning to produce higher bookings and revenue each quarter. Also
during the quarter, Digirad added Johns Hopkins Medical Center, one
of the nation's premiere academic medical centers, to its centers
of influence. The Company began this program less than a year ago,
now has working relationships with six centers of influence, and
expects to sign at least four additional centers by the end of
2008. Casner added: "The results of our centers of influence
strategy are encouraging, but we feel it is too early to offer a
definitive outlook. However, as this expansion continues to gain
traction, we'll be able to better understand and predict not only
the revenue implications but also the timing of those revenue
flows." First-Quarter 2008 Financial Summary: -- Consolidated
revenues were $18.3 million, compared to $17.5 million in
first-quarter 2007. -- Digirad Imaging Solutions (DIS) revenue rose
13.6 percent to $13.9 million from $12.2 million in first-quarter
2007, due primarily to the introduction of ultrasound imaging
services. -- Product-related revenue was $4.4 million, compared to
$5.3 million in first-quarter 2007, due to fewer camera sales
resulting from healthcare imaging reimbursement pressures and the
slowing economy. -- Gross profit declined to $4.4 million from $5.4
million in first-quarter 2007, due primarily to lower camera sales,
and higher labor and other servicing costs related to DIS. -- Total
operating expenses rose to $6.1 million from $5.9 million in
first-quarter 2007 due to higher amortization costs from the
acquisition of Ultrascan in the second-quarter 2007. -- Net loss
for the quarter was $1.4 million, or $(0.07) per share, compared to
net profit of $74,000, or $0.00 per share, in first-quarter 2007.
The Company's plan to stabilize growth of services revenues and
reduce the effects of the economy and other market pressures
includes not only continuing to drive the centers of influence
strategy to augment direct sales and marketing to physicians but
also a broader range of imaging services and, therefore, revenue
sources. During first quarter Digirad began a pilot program to
evaluate a new diagnostic ultrasound procedure to complement its
current imaging services. Physicians enrolled with DIS who are
participating in the pilot program are finding that additional
vascular imaging can enhance patient care. All primary-care
physicians using DIS ultrasound services may soon be able to offer
this new service to their patients. Casner stated: "We will
continue to pilot this program during the next few quarters and, if
indications remain positive, anticipate rolling out this new
service to the larger number of our DIS physicians who lease our
ultrasound imaging services. Due to the way the new procedure
easily fits into our current process, we would also be able to
leverage our existing ultrasound infrastructure." Other
First-Quarter 2008 Updates: -- DIS fleet upgrades: seven multi-head
Cardius XPO cameras were added to Digirad's mobile imaging services
fleet during the quarter; 82 percent of DIS' mobile fleet, or 68
systems, have been upgraded. The upgrades of the entire fleet are
expected to be completed during second-quarter 2008. -- Asset
utilization was 64 percent of 143 systems (nuclear and ultrasound),
compared to 58 percent of 82 systems (all nuclear) for
first-quarter 2007. -- Cash and equivalents and securities
available for sale on March 31, 2008, totaled $26.4 million,
compared to $31.7 million on December 31, 2007. -- Cash usage
during the quarter included $2.6 million for operations and $2.6
million for capital expenditures to expand the Company's mobile
imaging services business. -- Receivables on March 31, 2008, were
$9.8 million, compared to $8.5 million on December 31, 2007. --
Inventories on March 31, 2008, were $5.8 million compared to $5.5
million on December 31, 2007. Management Updates Guidance for
Full-Year 2008 Considering current economic pressures, the
early-growth phase of the Company's centers of influence, and
continued volatility with its business, management anticipates
consolidated revenues in a range of $75 million to $81 million,
consisting of DIS revenue of $56 million to $60 million and
product-related revenue of $19 million to $21 million. Management
expects a consolidated net loss in a range of $2.0 million to $4.5
million, including estimated stock-based compensation expense of $1
million. Conference Call Information A conference call is scheduled
for 11:00 a.m. EDT today to discuss the results and management's
outlook. A simultaneous web cast of the call may be accessed online
from the Events & Presentations link on the Investor Relations
page at http://www.digirad.com/; an archived replay of the webcast
will be available within 15 minutes of the end of the conference
call. About Digirad Digirad Corporation provides diagnostic nuclear
and ultrasound imaging systems and services to physicians' offices,
hospitals and other medical services providers for cardiac,
vascular, and general imaging applications. Digirad's Cardius XPO
line of nuclear imaging cameras use patented solid-state technology
and unique multi (dual, triple) head design for superior
performance and advanced features for sharper digital images,
faster processing, compact size, lighter weight for portability,
ability to handle patients up to 500 pounds, and improved patient
comfort compared to standard nuclear cameras. Digirad's 2020tc
general-purpose nuclear imager has a small footprint and may also
be configured for fixed or mobile use to supplement primary
imaging. Digirad's installed base of equipment exceeds 500 systems;
in addition, a mobile fleet of more than 143 nuclear and ultrasound
imaging systems is being used in 22 states and the District of
Columbia, primarily in the eastern, midwestern and southwestern
United States. For more information, please visit
http://www.digirad.com/. Digirad(R), Digirad Imaging Solutions(R),
and Cardius(R) are registered trademarks of Digirad Corporation.
Forward-Looking Statements Statements in this press release that
are not a description of historical facts are forward-looking
statements. You can identify these statements by the fact that they
do not relate strictly to historical or current facts and use words
such as "anticipate," "estimate," "expect," "project," "intend,"
"plan," "believe" and other words and terms of similar meaning.
Examples of such forward looking statements include statements
regarding revenues, gross margins, operating expenses, performance
and cost benefits from the ongoing upgrade of the mobile imaging
fleet, anticipated revenue in 2008 from the Company's centers of
influence strategy, potential acquisitions, and, in general,
anticipated financial results for 2008. Actual performance and
benefits results may differ materially from those set forth in this
press release due to risks and uncertainties inherent in Digirad's
business including, without limitation, changes in business
conditions, technology, customers' business conditions, work force,
suppliers, business prospects, economic outlook, operational policy
or structure, acceptance and use of Digirad's camera systems and
services, reliability, recalls, and other risks detailed in
Digirad's filings with the U.S. Securities and Exchange Commission,
including Annual Report on Form 10-K, Quarterly Reports on Form
10-Q, Form 8-K and other reports. Readers are cautioned to not
place undue reliance on these forward-looking statements, which
speak only as of the date hereof. All forward-looking statements
are qualified in their entirety by this cautionary statement, and
Digirad undertakes no obligation to revise or update the
forward-looking statements contained herein. Investor Contact:
Company Contact: Dan Matsui Todd Clyde, CFO Allen & Caron
858-726-1600 949-474-4300 Digirad Corporation Condensed
Consolidated Statements of Operations (In thousands, except per
share amounts) (Unaudited) Three Months Ended March 31, 2008 2007
Revenues: DIS $13,854 $12,197 Product 4,417 5,341 Total revenues
18,271 17,538 Cost of revenues: DIS 10,912 8,938 Product 2,946
3,158 Total cost or revenues 13,858 12,096 Gross profit 4,413 5,442
Operating expenses: Research and development 644 782 Sales and
marketing 2,119 2,098 General and administrative 3,159 2,972
Amortization of intangible assets 190 6 Total operating expenses
6,112 5,858 Loss from operations (1,699) (416) Interest income, net
306 464 Other income (expense) (2) 26 Net income (loss) $(1,395)
$74 Net income (loss) per share: Basic and diluted $(0.07) $0.00
Weighted average shares outstanding: Basic 18,931 18,815 Diluted
18,931 19,200 Stock-based compensation expense is included in the
above as follows: Cost of DIS revenue $17 $25 Cost of Product
revenue 11 26 Research and development 13 23 Sales and marketing 24
50 General and administrative 115 150 Digirad Corporation Condensed
Consolidated Balance Sheets(1) (in thousands) March 31, December
31, 2008 2007 (unaudited) Assets Cash and cash equivalents $15,568
$14,922 Securities available-for-sale 8,304 16,740 Accounts
receivable, net 9,772 8,536 Inventories, net 5,804 5,455 Other
current assets 2,133 1,786 Total current assets 41,581 47,439
Property and equipment, net 17,494 16,235 Intangible assets, net
2,441 2,631 Goodwill 2,650 2,650 Securities available-for-sale
2,500 -- Restricted cash 60 60 Total assets $66,726 $69,015
Liabilities and stockholders' equity Accounts payable $2,648 $2,650
Accrued compensation 2,843 3,547 Accrued warranty 785 930 Other
accrued liabilities 3,036 3,285 Deferred revenue 2,922 2,909
Current portion of long-term debt 142 213 Total current liabilities
12,376 13,534 Long-term debt, net of current portion 75 -- Deferred
rent 211 234 Total stockholders' equity 54,064 55,247 Total
liabilities and stockholders' equity $66,726 $69,015 (1) The
condensed consolidated balance sheet as of December 31, 2007, has
been derived from the audited financial statements as of that date.
DATASOURCE: Digirad Corporation CONTACT: Investors, Dan Matsui of
Allen & Caron, +1-949-474-4300, for Digirad Corporation; or
Todd Clyde, CFO of Digirad Corporation, +1-858-726-1600, Web site:
http://www.digirad.com/
Copyright
Digirad (NASDAQ:DRAD)
Historical Stock Chart
From May 2024 to Jun 2024
Digirad (NASDAQ:DRAD)
Historical Stock Chart
From Jun 2023 to Jun 2024